Trial intelligence / Profile preview

Adalimumab in rheumatoid arthritis assessed by whole-body and dedicated MRI and CT

2009-014394-41Phase 4Completed

Sponsor
Copenhagen University Hospital - Hvidovre
Start
Sep 2009
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Countries
1
01

Overview

Phase 4, single-arm trial of adalimumab in rheumatoid arthritis (RA), sponsored by Copenhagen University Hospital - Hvidovre. Primary endpoints: Primary imaging efficacy measures and Comparison of imaging modalities for wrist and MCP joints. Started Sep 2009; status: completed.

02

Drugs

03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on 2009-014394-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-014394-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call